Comment on 'What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion'

Drugs. 2016 Jul;76(10):1059-61. doi: 10.1007/s40265-016-0593-0.

Authors

Raffaele Giusti¹, Lucilla Verna^{2

3}, Daniela Iacono⁴, Agnese Vannini³, Corrado Ficorella², Giampiero Porzio^{2

3}

Affiliations

¹ Medical Oncology Unit, Sant'Andrea Hospital of Rome, Via di Grottarossa 1035-39, 00189, Rome, Italy. raffaelegiusti@yahoo.it.
² Medical Oncology Unit, University of L'Aquila, L'Aquila, Italy.
³ Associazione Tumori Toscana, Home Care Service, Florence, Italy.
⁴ Medical Oncology Unit, Sant'Andrea Hospital of Rome, Via di Grottarossa 1035-39, 00189, Rome, Italy.

PMID: 27312430
DOI: 10.1007/s40265-016-0593-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Analgesics, Opioid / therapeutic use
Breakthrough Pain / drug therapy
Cancer Pain*
Humans
Neoplasms / drug therapy
Pain Measurement

Substances

Analgesics, Opioid